Keyword :   disease-modifying antirheumatic drugs

REVIEW OF EULAR CONGRESS 2022
Author:The editors of the magazine «Ukrainian Medical Journal» №89–90 (3–4) 2022 / Review: 40
Seronegative rheumatoid arthritis: response to treatment with disease modifying antirheumatic drugs compared to seropositive variants of the disease
Authors: Yaremenko O.B. Mykytenko G.M. №60 (2) 2015 / Review: 8
New strategy of rheumatoid arthritis therapy (on the base of 2013 update recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs)
Authors: Kovalenko V.M. Bortkevych O.P. Biliavska Yu. №54 (4) 2013 / Review: 12
Pharmacotherapy of rheumatoid arthritis: a modern approach to the problem
Authors: Rudyuk L.I. Kharitonova E.M. №54 (4) 2013 / Review: 7
Antidestructive influence of disease modifying antirheumatic drugs in patients with very early, early and late rheumatoid arthritis
Authors: Yaremenko O.B. Mykytenko G.M. №53 (3) 2013 / Review: 14
clinical and radiological associations in different Variants of disease modifying therapy of rheumatoid arthritis
Authors: Yaremenko O.B. Mykytenko G.M. №52 (2) 2013 / Review: 5
INFLUENCE OF THE IMMUNE STATUS AND LIPID FACTORS ON SUBCLINICAL ATHEROSCLEROSIS PROGRESSION AND DEVELOPMENT OF THE CARDIOVASCULAR DISEASES IN PATIENTS WITH RHEUMATOID ARTHRITIS
Authors: Kovalenko V.M. Khimion L.V. Lysenko G. Garmish E.A. №43 (1) 2011г. / Review: 12
THE BASIC PRINCIPLES OF PATIENTS WITH RHEUMATOID ARTHRITIS MANAGEMENT ACCORDING TO RECENT EUROPEAN LEAGUE AGAINST RHEUMATISM RECOMMENDATIONS (2010)
Authors: Kovalenko V.M. Shuba N.M. Bortkevych O.P. Biliavska Yu. №42 (4) 2010 г. / Review: 35